Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT05481840
Other study ID # AHD19.022
Secondary ID 80-85300-98-1911
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date July 28, 2021
Est. completion date February 28, 2023

Study information

Verified date July 2022
Source Academy Het Dorp
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Background and study aims Most people with profound intellectual and multiple disabilities (PIMD) use diapers. When living in a long-term care facilities, most changes of diapers are scheduled. Leading to leakages, unnecessary changes and burden to people with PIMD and their caregivers. With the use of continence material with sensor (smart diapers) caregivers give more client-based continence care. The smart diaper (product name: Abena Nova) informs the caregivers about the saturation level of the diaper and gives a notification when change is needed or a leakage might occur. This can result in less leakages compared to regular continence care. And we will research the effect on quality of life and number of pad changes and cost effectiveness. The study also investigates the effect on the care givers. Who can participate? People with profound intellectual and multiple disabilities, of 18 years and older, who use diapers and live in one of the participating disability care organizations. What does the study involve? To investigate the effect, the disability care organization will be assigned to one of the two groups. In one group we will research the use of the smart diaper, the other group will continue their regular continence care. Data collection started September 2021 and will continue roughly till February 2023. Research period for each location is 12 weeks, with 3 points for data collection. For the first two organization who are using the smart diaper, there is also data collection after 9 months. Caregivers will fill out questionnaires about the quality of life, received healthcare of the participant, and keep a one week diary about the diaper changes and leakages. To use the smart diaper, caregivers will receive training, there are meetings to optimize usage and the disability care organization will receive help from the researchers. Possible benefits and risk of participating? The potential benefit of participating lays within the organization itself, optimizing continence care and investigating whether this is cost effective. Any negative effect is the cost of the product and the additional time and effort it takes to start using smart diapers. For the patients the benefit is getting more optimized continence care. Any potential discomfort or risk (such as removing of swallowing the sensor) will be evaluated before the start. Any negative advice will result in not implementing the smart diaper for this person showing risk behavior. However, any of these adverse events cannot be complete diminished. Where does the study run from? Study is run by Academy Het Dorp, one of the researcher is also affiliated with Tranzo, Tilburg University Who is funding the study? ZonMW is funding the research activities. Disability care organization are themselves paying for the smart diapers. Who is the main contact? Vivette van Cooten, MSc Vivette.van.cooten@academyhetdorp.nl


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 160
Est. completion date February 28, 2023
Est. primary completion date February 28, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion: - Age: =18 years - Gender: male of female - People with PIMD - Living in a long-term care facility - Using continence pads - Not able to indicate the need for change of continence pads - Caregivers see added value for use of smart continence pads Exclusion: - No informed consent of legal representative - Risk of harmful behavior such as pica disorder

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Continence material with sensor
Healthcare organizations are prepared for the use of smart continence care (for the intervention condition) using specially developed implementation guideline. They receive training, including how to apply continence material (only provided to intervention condition). Each participating location will use the product for 12 weeks. Correct size and absorption level will be determined for each participant. The optimize the result, this can change. Evaluation meetings with the caregivers, supplier and researcher will be held. Resulting in suggestions for alterations in continence care provided or products used, or giving indications that a team needs support in any way to foster the implementation. After 12 weeks, the implementation guidance from the research group will be phased out. The waiting list group will continue their continence care as usual during data collection period. Thereafter they will receive support for implementing smart continence care.

Locations

Country Name City State
Netherlands 's Heeren Loo Amersfoort
Netherlands Siza Arnhem
Netherlands Lunet Eindhoven
Netherlands Esdégé-Reigersdaal Heerhugowaard
Netherlands Zozijn Wilp

Sponsors (9)

Lead Sponsor Collaborator
Academy Het Dorp Esdégé-Reigersdaal, Lunet, Maastricht University, s Heeren Loo Zorggroep, Siza, Tilburg University, Trimbos-instituut, Zozijn

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in baseline of number of leakages of continence pads per week at 12 weeks Measured by using a week long continence diary Baseline (week 0) and at 12 weeks
Secondary Change in number of changes of continence pads per week Measured using a week long continence diary Baseline (week 0), week 6, week 12 and 9 months
Secondary Health status measured by EuroQoL (Quality of Life)-5 Dimensions (EQ-5D-5L proxy 1) of people with PIMD Proxy (healthcare provider and if available relative) of person with PIMD fills out EuroQoL (EQ-5D-5L proxy 1) questionnaire resulting in a health status and VAS score of health of the person with PIMD. Baseline (week 0), week 12 and 9 months
Secondary Subjective wellbeing scores assessed by MIPQ of people with PIMD Proxy (healthcare provider and if available relative) of person with PIMD fills out Mood Interest and Pleasure questionnaire about person with PIMD, resulting in an overall score of subjective wellbeing between 0 (lowest subjective wellbeing score) and 100 (highest subjective wellbeing score). Baseline (week 0), and week 12
Secondary Objective quality of life scores assessed by QOL-PMD of people with PIMD Proxy (healthcare provider and if available relative) of person with PIMD fills out Quality of Life of people with Profound Multiple Disabilities questionnaire about person with PIMD, resulting in an overall score of objective wellbeing between 0% (lowest objective quality of life score) and 100% (highest objective quality of life score). Baseline (week 0), and week 12
Secondary Cost effectiveness of providing smart continence care The cost effectiveness is measured by calculating the costs of the intervention and compare it with the financial benefits (cost reductions) due to the intervention. This includes direct healthcare costs (healthcare resource use) and related costs as laundry costs. at week 6, week 12 and 9 months
Secondary Cost utility of providing smart continence care It calculates the financial costs (resulting from cost effectiveness analysis) to the additional QALY's (quality adjusted life years) gained when using smart continence care, compared to not using smart continence care. QALY is the outcome of the EUROQOL, health state. The Dutch tariff will be used to calculate the QALY from these health states. at week 12 and 9 months
Secondary Effect on work engagement for caregivers when using smart continence care This questionnaire includes questions about work pressure and satisfaction. Baseline (week 0) and week 12
See also
  Status Clinical Trial Phase
Completed NCT02835846 - Investigation of the Effect of the Female Urinary Microbiome on Incontinence Phase 4
Recruiting NCT02978638 - Electrical Stimulation for Continence After Spinal Cord Injury N/A
Completed NCT01978210 - Development of a Manualized Wireless Moisture Pager Intervention for Teaching Toileting in Children With Autism N/A
Completed NCT01036035 - Effects of Novel Combinations of Tolterodine/Pilocarpine on Pharmacokinetics (PK) and Pharmacodynamics (PD) of Tolterodine in Healthy Subjects Phase 1
Completed NCT00972998 - Study to Examine the Effect of Coated Phenylephrine Suppositories on Anal Pressure in Healthy Subjects Phase 1/Phase 2
Recruiting NCT04110821 - Quality of Life After Conservative and Surgical Treatment of Pelvic Organ Prolapse
Recruiting NCT05826691 - Benign Prostate Surgery and QOL and Sexual Function
Recruiting NCT05362292 - TReating Incontinence for Underlying Mental and Physical Health Phase 4
Recruiting NCT05935371 - Consequences of Obstetric Anal Sphincter Injuries on Maternal Psychology and Relationship Experience
Completed NCT02554201 - Efficacy of Electrical Pudendal Nerve Stimulation for Neurogenic Lower Urinary Tract Dysfunction N/A
Completed NCT01486706 - Efficacy and Safety of Gabapentin in Treating Overactive Bladder Phase 2/Phase 3
Completed NCT00617786 - CPT Testing for Sacral Neuromodulation Outcomes N/A
Completed NCT02633592 - Seated Evaluation of Anorectal funcTion by High Resolution Anorectal Manometry N/A
Completed NCT01747343 - Toilet Training Toddlers and Preschoolers N/A
Completed NCT01470001 - The Effect of Solifenacin on Post Void Dribbling in Women N/A
Recruiting NCT02091947 - Efficacy of Functional Magnetic Stimulation in Urinary Incontinence Phase 2
Completed NCT01108367 - Transient Urinary Incontinence After Holmium Laser Enucleation of the Prostate (HoLEP) N/A
Completed NCT04924218 - Evaluation of the Effect of Endoscopic Urethral Procedures Applied After Radical Prostatectomy on Urinary Incontinence N/A
Recruiting NCT04010292 - Enhancing Patient Recall in Urogynecologic Surgery N/A
Completed NCT05106010 - The Effect of Yoga on Decreasing Risk of Fall-Related Injury in Peri and Post-Menopausal